SCHEMBL732152

SCHEMBL732152

N#Cc1ccc(Cl)nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3294798 0.84 EGLN2 (0.41)
SCHEMBL16701831 0.75
SCHEMBL12804843 0.75
SCHEMBL29367162 0.74
SCHEMBL111337 0.74
SCHEMBL24942537 0.72 EGLN2 (0.36)
SCHEMBL34471428 0.71 ALDH1A1 (0.35)
Ammonia Solution, Strong SCHEMBL25301697 0.71
SCHEMBL1777965 0.70
SCHEMBL21603306 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 401 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108059205-A For the up-flow adsorptive reactor of orthophosphates in Adsorption waste water 北京益清源环保科技有限公司 2018-05-22 CN claimed
US-20260091048-A1 GIP RECEPTOR AGONIST COMPOUNDS LILLY CO ELI (US) 2026-04-02 US disclosed
US-12570671-B2 Substituted oxoisoindoline compounds for the treatment of cancer BRISTOL-MYERS SQUIBB COMPANY (US) 2026-03-10 US disclosed
EP-4126843-B1 SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER BRISTOL MYERS SQUIBB CO (US) 2026-02-11 EP disclosed
US-20260001870-A1 INHIBITOR COMPOUNDS Cincera Therapeutics Pty Ltd (AU) 2026-01-01 US disclosed
EP-4634169-A1 3-FLUORO-4-HYDROXYBENZMIDE-CONTAINING INHIBITORS AND/OR DEGRADERS AND USES THEREOF Pfizer Inc. (US) 2025-10-22 EP disclosed
US-12448371-B2 Inhibitor compounds Cincera Therapeutics Pty Ltd (AU) 2025-10-21 US disclosed
EP-4598908-A1 HSD17B13 INHIBITORS AND/OR DEGRADERS Pfizer Inc. (US) 2025-08-13 EP disclosed
US-12378218-B2 Cyclopentane compounds DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2025-08-05 US disclosed
WO-2025120168-A1 SULFONAMIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF CRYPTOSPORIDIUM INFECTIONS INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (INRAE) (FR) 2025-06-12 WO disclosed
WO-1999064416-A2 OXAZOLIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ASTRAZENECA AB (SE) 1999-12-16 WO disclosed
WO-1999064417-A2 OXAZOLIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ASTRAZENECA AB (SE) 1999-12-16 WO disclosed
US-5994353-A ANTIARTHRITIC AGENTS; ANALGESICS; ANTIINFLAMMATORY AGENTS ZENECA LIMITED (GB) 1999-11-30 US disclosed
WO-1998058929-A1 ANGIOGENESIS INHIBITING THIADIAZOLYL PYRIDAZINE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1998-12-30 WO disclosed
EP-0835246-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ZENECA LIMITED (GB) 1998-04-15 EP disclosed
WO-1997000863-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ZENECA LIMITED (GB) 1997-01-09 WO disclosed
EP-0208431-B1 FUNGICIDAL PYRIDAZINES ELI LILLY AND COMPANY (US) 1990-07-11 EP disclosed
US-4791110-A FOR PHYCOMYCETES ON PLANTS ELI LILLY AND COMPANY (US) 1988-12-13 US disclosed
EP-0208431-A1 Fungicidal pyridazines ELI LILLY AND COMPANY (US) 1987-01-14 EP disclosed
US-3962242-A BACTERIOSTATS, URINARY TRACT INFECTIONS BOEHRINGER MANNHEIM G.M.B.H. (DT) 1976-06-08 US disclosed